logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Ralph New Harris, Iii

This inventor holds 24 USPTO granted patents and 5 published patent applications, primarily in Pharmaceutical Chemistry. Top assignees: Roche Palo Alto LLC, Syntex (u.s.a.) Inc., Sri International. Active years: 1989-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralph New Harris, Iii. Retrieved from https://idiyas.com/inventor/ralph-new-harris-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 33.3

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 107(Granted Patents)


Company Filing History:

goldMedal17 out of 322 
 
Roche Palo Alto LLC
 patents
silverMedal5 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal2 out of 1,360 
 
Sri International
 patents

Years Active: 1989-2017

Loading Chart...
Areas of Expertise:
Tetralin Derivatives
Quinolinone Derivatives
P2X7 Modulators
Muscarinic Receptor Antagonists
Arylsulfonyl Compounds
Indole Derivatives
Aldoxime-Substituted Compounds
Heterocyclylalkylamines
Arylsulfonamidyl Compounds
Triazolium Compounds
5-HT6 Receptor Affinity
24 patents (USPTO):Explore Patents
1. 9670151 - Tetralin and indane derivatives and uses thereof (2017-06-06),
2. 8889906 - Tetralin and indane derivatives and uses thereof (2014-11-18),
3. 8871760 - [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators (2014-10-28),
4. 8093424 - Tetralin and indane derivatives and uses thereof (2012-01-10),
5. 7981923 - Tetralin and indane derivatives and uses thereof (2011-07-19),
6. 7799797 - Arylsulfonyl naphthalene derivatives and uses thereof (2010-09-21),
7. 7671235 - Tetralin and indane derivatives and uses thereof (2010-03-02),
8. 7576103 - Tetralin and indane derivatives and uses thereof (2009-08-18),
9. 7531577 - Arylsulfonamidyl tetralin derivatives and uses thereof (2009-05-12),
10. 7476675 - Quinolinone derivatives and uses thereof (2009-01-13),
11. 7473690 - Tetralin and indane derivatives and uses thereof (2009-01-06),
12. 7361648 - Heterocyclylakylamines as muscarinic receptor antagonists (2008-04-22),
13. 7312359 - Tetralin and indane derivatives and uses thereof (2007-12-25),
14. 7307089 - Aryloxy quinolines and uses thereof (2007-12-11),
15. 7229984 - Dibenzoxazepinone derivatives and uses thereof (2007-06-12),

Title: The Innovative Journey of Inventor Ralph New Harris, III

Introduction:

Ralph New Harris, III, a prolific inventor based in Redwood City, CA, has made significant contributions to the field of pharmaceuticals with a remarkable 24 patents to his name.

Latest Patents:

His latest patents include groundbreaking advancements in the realm of Tetralin and indane derivatives and their various uses. These compounds, formulated as per the formula I, exhibit immense potential in the pharmaceutical industry. The patents cover the synthesis, compositions, and applications of these compounds, paving the way for novel pharmaceutical products.

Career Highlights:

Having worked with reputable companies such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc., Ralph New Harris, III has honed his skills and expertise in the pharmaceutical sector. His innovative spirit and dedication have led to the successful development of numerous patented inventions.

Collaborations:

Throughout his career, Ralph New Harris, III has collaborated with esteemed professionals in the field, including David Bruce Repke and Russell Stephen Stabler. Together, they have spearheaded projects, shared knowledge, and achieved remarkable milestones in pharmaceutical innovation.

Conclusion:

Inventor Ralph New Harris, III stands as a beacon of innovation in the pharmaceutical industry, with his multitude of patents and groundbreaking contributions. His collaborations and career highlights underscore his commitment to advancing pharmaceutical research and development, ultimately shaping the landscape of modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…